AstraZeneca's Imfinzi becomes the first cancer immunotherapy to be FDA-approved for limited-stage small cell lung cancer (LS-SCLC). Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-ti...
“According to a radio newscast I heard while in my car during the Iraq war, a lone Moslem in the city of Baghdad had been screaming, “Hey, look what God is doing to the U.S. Forces.” Upon hearing this, I scoured the newspapers for any news about what this gentl...
AstraZeneca Pharmaceuticals LP. 45. Nassar AH, Adib E, Kwiatkowski DJ. Distribution of KRASG12C somatic mutations across race, sex, and cancer type [correspondence]. N Engl J Med. 2021;384(2):185-187 [supplementary appendix 2]. 46. Aggarwal C, Thompson JC, Black TA, et al. Clinical ...
Many Serbs living in European Union countries intend to return to Serbia, as do many from neighbouring countries, to get vaccinated because vaccination rates in EU member states are relatively low because of slow vaccine supply by US company Pfizer and British-Swiss firm AstraZeneca. Perhaps inspi...
BCAM was created by the Imperial Chemical Company, since bought out by AstraZeneca, which was recognized at the time of the inception of the BCAM as the second largest producers of carcinogens in the United States. Imperial Chemical was soon joined by chemical companies, cosmetic companies, food...